ZERONDA TYLER (Interim CFO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/3/2021ACC: 0001209191-21-054837
Officer· Interim CFO
Since Jun 2021
+121.72K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
121.72K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60.86K
Price / share
—
Trade value
—
% of position
268.2%
9/2/2021
22.70K→83.55K
Total
Net shares
+60.86K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2021 | A · Award | +60.86K | — | — | 268.2% | 22.70K | 83.55K |
| Total | +60.86K | $0.00 | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Stock
60.86K shares
Shares
+60.86K
Strike price
1.68
Held after
60.86K
Exercisable
—
9/2/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock60.86K shares | 9/2/2021 | A · Award | +60.86K | 1.68 | — | 60.86K |